Development of allergy post-bone marrow transplantation

References: 1 Bensinger WI, Martin PJ, Storer B et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with haematological cancers. N Engl J Med 2001; 344:175-81. 2 Chakrabarti S, Mackinnon S, Chopra R et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood 2002; 99:4357-63. 3 Agosti JM, Sprenger JD, Lum LG et al. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med 1988; 319:1623-8. 4 Bellou A, Kanny G, Fremont S, Moneret-Vautin DA. Transfer of atopy following bone marrow transplantation. Ann Allergy Asthma Immunol 1997; 78:513-6. 5 Heyd J, Donnenberg AD, Burns WH, Saral R, Santos GW. Immunoglobulin E levels following allogeneic, autologous and syngeneic bone marrow transplantation: an indirect association between hyperproduction and acute graft-v-host disease in allogeneic BMT. Blood 1988; 72:442-6. 6 Walker SA, Riches PG, Wild G et al. Total and allergen-specific IgE in relation to allergic response pattern following bone marrow transplantation. Clin Exp Immunol 1986; 66:633-9. 7 Ringden O, Persson U, Johansson SGO et al. Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. Blood 1983; 61:1190-5. 8 Korver K, Schellekens PTA, Dooren LJ, Vossen JM. Transient elevation of serum IgE after allogeneic bone-marrow transplantation. Int Archs Allergy Appl Immun 1987; 84:45-55. 9 Sindel LJ, Buckley RH, Schiff SE et al. Severe combined immunodeficiency with natural killer-cell predominance: abrogation of graft-versus-host disease and immunological reconstitution with HLA-identical bone marrow cells. J Allergy Clin Immunol 1984; 73:829-36. 10 Bengtsson M, Gordon J, Flores-Romo L et al. B-cell reconstitution after autologous bone marrow transplantation: increase in serum CD23 ('IgE binding factor') precedes IgE and B-cell regeneration. Blood 1989; 73:2139-44. 11 Krenger W, Hill GR, Ferrara JL. Cytokine cascades in acute graft-versus-host disease. Transplantation 1997; 64:553-8. 12 Smith SR, Macfarlane AW, Lewis-Jones MS. Papular urticaria and transfer of allergy following bone marrow transplantation. Clin Exp Dermatol 1988; 13:260-2. 13 Lucke TW, Bong JL, Clark D, Murphy JA. Passive transfer of contact hypersensitivity to rubber following allogeneic bone marrow transplantation. Br J Dermatol 1999; 141:931-55. 14 Shalit M, Amar A, Or R. Allergy development after bone marrow transplantation from a non-atopic donor. Clin Exp Allergy 2002; 32:1698-700. 15 Garraud O, Mollis SN, Holland SM et al. Regulation of immunoglobulin production in hyper-IgE (Job's) syndrome. J Allergy Clin Immunol 1999; 103:333-40. 16 Gennery AR, Flood TJ, Abinun M, Cant AJ. Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant 2000; 25:1303-5. 17 Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27:893-8. 18 Takatsuka H, Takemoto Y, Yamada S et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 2000; 26:419-26. 19 Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. Kinetics of dendritic cell activation. impact on priming of Th1, Th2 and nonpolarized T cells. Nature Immunol 2000; 1:311-6. 20 Elenkov IJ, Chrousos GP. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibilty to disease. Trends Endocrinol Metab 1999; 10:359-68. 21 Agarwal SK, Marshall GD Jr. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J Interferon Cytokine Res 2001; 21:147-55.